Bupropion vs Ipilimumab

Bupropion vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Bupropion and Ipilimumab.

Mechanism of Action

Bupropion: Norepinephrine-dopamine reuptake inhibitor (NDRI).

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Bupropion — 21 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Bupropion — C13H18ClNO.

Molecular Weight: Bupropion — 239.7420 g/mol.

Type: Bupropion — Small molecule; Ipilimumab — Antibody.